MDGL
MDGL
NASDAQ · Biotechnology

Madrigal Pharmaceuticals Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$509.76
-3.67 (-0.71%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 20 87%
Hold 3 13%
Sell 0 0%
Price Target
Analyst Price Target -76.5% upside
Low Target $78.20
Average Target $119.83
High Target $127.79
Current Price $509.76
Current
$509.76
Target
$119.83
$78.20 $119.83 avg $127.79
Scenario Analysis
Bear Case
$78.20
-84.7%
Low target
Base Case
$119.83
-76.5%
Avg target
Bull Case
$127.79
+-74.9%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$615.00
-17.1% from high
52-Week Low
$275.00
+85.4% from low
50-Day SMA
$526.21
-3.1% vs SMA
200-Day SMA
$421.32
+21.0% vs SMA
RSI (14)
32.6
Neutral
Target vs 52W High
$119.83
-80.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%